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unclear which factorsmay play a role inmodiﬁcation of healthy and un-
healthy obesity phenotypes.
Therefore, studying the relationship between lipid metabolism and
the status of metabolically healthy or unhealthy obese individuals is of
considerable interest.
In this issue of EBioMedicine, Ni et al. report the association of circu-
lation FA proﬁle with metabolic status of obese individuals (Ni et al.,The epidemic of obesity and type 2 diabetes represents themost fre-
spectrumof circulating free fatty acid (FFA) from452 individuals of nor-
mal weight (NW), metabolically health (MHO) and unhealthy obesequent causes ofmorbidity andmortality in developed countries. Obesity
is associated with an increased risk of developing metabolic syndrome,
hypertension, premature coronary heart disease and stroke. The ad-
verse metabolic effects of obesity may in part be mediated by disorders
of lipid metabolism. Normal cellular lipid homeostasis is characterized
by the balance between processes that generate or deliver fatty acids
(FAs) and processes that utilize these molecules. FAs serve as energy
substrate and are important structural component of cell membrane
or they are precursors of eicosanoids and regulators of gene expression
(Shulman, 2000). In obesity, large amounts of FAs are stored in adipo-
cytes fromwheremay bemobilized and excess of circulating FA and tri-
glycerides leads to the increased lipid accumulation in non-adipose
tissues where lipid overload is associated with adverse consequences
(Lewis et al., 2002). In skeletal muscle ectopic fat storage, in particular
the accumulation of lipid metabolism intermediates (diacylglycerol,
long-chain fatty acyl CoA) is suspected to play a key role in the genesis
of insulin resistance by interfering with insulin signaling, glucose utili-
zation and by inducing inﬂammatory pathways (Corcoran et al.,
2007). In liver, ectopic lipid accumulation (steatosis) occurs when the
rate of FA uptake from circulation and de novo FA synthesis is greater
than the rate of FA oxidation and export (as triglycerides in very low
density lipoproteins). Lipid overload in pancreatic β-cell leads to dys-
regulated insulin secretion. There is also evidence that excess of FA
causes β-cell apoptosis (Prentki et al., 2002; Kazdová et al., 2002).
Recent meta-analysis of clinical studies provides evidence that not
all obese subjects are at increased risk for metabolic disorders, diabetes,
and cardiovascular disease. Nearly one-third of obese adults are consid-
eredmetabolically healthy with the absence of any metabolic disorders
such as dyslipidemia, hypertension, insulin resistance (Bell et al., 2014).2015.09.004.
. This is an open access article under2015). The authors performed metabolomics approach to measure
subjects (MUO), further before and after weight loss intervention. In
the cross-sectional study, FFA levels were found signiﬁcantly higher in
overweight/obese subject with type 2 diabetes in comparisonwith nor-
mal weight or healthy obese subjects. In particular, the higher propor-
tion of dihomo-gamma-linolenic acid (DGLA) and palmitoleic acid
wasmetabolicmarkers associatedwith unhealthy obese individuals. In-
terestingly, the same differences were also found up to ten years before
the onset of metabolic syndrome. The weight loss intervention in obese
subjects through metabolic surgery or very low caloric diet, improved
metabolic disorders and decreased levels of unsaturated fatty acids in-
cluding DGLA and palmitoleic acid. The authors conclude that some un-
saturated FA may have potential role in pathogenesis of metabolic
disorders associated with metabolic syndrome and may be a marker
in predicting the risk of developing diabetes in obese individuals.
It iswell known that increased blood FFA levels have a key role in the
development of impaired insulin signal pathways, insulin resistance
and type 2 diabetes. However, different kinds of FFA have different ef-
fects on carbohydrate and lipid metabolism.
The FA proﬁle in circulation reﬂects dietary FA intake but is also
inﬂuenced by the endogenous FA metabolism, mainly by the action
of desaturase enzymes (Δ5, Δ6) which catalyze the conversion of
linoleic acid and linolenic acid into long-chain polyunsaturated FAs
and stearoyl coenzyme A desaturase (SCD) which are required for
the conversion of saturated FAs into monounsaturated FAs. It has
been published that increased SCD activity was associated with insu-
lin resistance, fatty liver and the metabolic syndrome and that high
delta-5 desaturase (D5D) activity was associated with lower diabe-
tes risk, whereas high delta-6 desaturase (D6D) activity had opposite
effects. It has been established that both high content of palmitoleic
acid and low D5D activity index have been described before as BMI-
independent predictors of insulin resistance and metabolic syn-
drome (Krōger and Schulze, 2012).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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FA from triglyceride stores in the adipose tissue. Conor et al. reported
that the release of FA into plasma correlated positively with
unsaturation and negatively with chain length whereas saturated FA
and oleic acid were much less released (Conor et al., 1996). Such a
difference could affect subsequent utilization and action of individual
FA in other tissues.
In conclusion, the observed difference in FA proﬁle of circulating FFA
between MHO and MUO, including the possibility of their inﬂuence by
weight loss intervention, suggests the potential role of individual FA as
importantmarker and targets for therapy of metabolic disorders associ-
atedwith insulin resistance and type 2 diabetes. A better understanding
of healthy and unhealthymetabolic state associatedwith obesity is nec-
essary to obtain more knowledge about the relationship between FA
proﬁles in other lipid fractions —mainly in phospholipids to metabolic
parameters.
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